Polymer Capital Management HK LTD Takes Position in SPDR S&P Biotech ETF $XBI

Polymer Capital Management HK LTD purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 48,200 shares of the exchange traded fund’s stock, valued at approximately $5,877,000. SPDR S&P Biotech ETF accounts for 0.8% of Polymer Capital Management HK LTD’s holdings, making the stock its 25th largest position.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Dynamic Wealth Strategies LLC raised its position in shares of SPDR S&P Biotech ETF by 3.8% during the 4th quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after buying an additional 80 shares in the last quarter. Capital Investment Advisory Services LLC raised its holdings in shares of SPDR S&P Biotech ETF by 4.0% in the 4th quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock worth $259,000 after purchasing an additional 81 shares in the last quarter. Compass Ion Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 2.6% during the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock valued at $474,000 after acquiring an additional 97 shares during the period. Moors & Cabot Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 3.8% during the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after acquiring an additional 100 shares during the period. Finally, Kingsview Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 1.8% during the third quarter. Kingsview Wealth Management LLC now owns 5,813 shares of the exchange traded fund’s stock valued at $582,000 after acquiring an additional 103 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $133.79 on Friday. The firm has a market capitalization of $8.54 billion, a P/E ratio of 11.47 and a beta of 0.85. The company’s 50 day simple moving average is $132.63 and its 200-day simple moving average is $127.12. SPDR S&P Biotech ETF has a 52-week low of $80.90 and a 52-week high of $139.19.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.